Evidence map›Paper›PMID 29970603›Full record

ArticleScience signaling2018

Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway.

Delphine Larrieu, Emmanuelle Viré, Samuel Robson, Sophia Y Breusegem, Tony Kouzarides, Stephen P Jackson

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Functional roles and mechanisms of NAT10-mediated RNA acFrontiers in cell and developmental biology · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. A critical role of NNature immunology · 2025
    Article
  17. Article
  18. Article
  19. The N-acetyltransferase 10 inhibitor [EJNMMI radiopharmacy and chemistry · 2025
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Delphine LarrieuThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK. dl437@cam.ac.uk s.jackson@gurdon.cam.ac.uk.ORCID 0000-0002-2335-9361
Emmanuelle ViréThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK.
Samuel RobsonThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK.
Sophia Y BreusegemThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK.
Tony KouzaridesThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK.ORCID 0000-0002-8918-4162
Stephen P JacksonThe Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN, UK. dl437@cam.ac.uk s.jackson@gurdon.cam.ac.uk.ORCID 0000-0001-9317-7937
The Gurdon Institute · GB

Funding

Cancer Research UK 10827Cancer Research UK 11224Cancer Research UK 17001Cancer Research UK 18796Cancer Research UK C6946/A24843Cancer Research UK C6/A18796Medical Research Council MR/L019116/1Medical Research Council RG17001Wellcome Trust 092096Wellcome Trust 206242/Z/17/ZWellcome Trust 206388/Z/17/ZWellcome Trust 86609Wellcome Trust WT203144
6 · The paper itself

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is an incurable premature aging disease. Identifying deregulated biological processes in HGPS might thus help define novel therapeutic strategies. Fibroblasts from HGPS patients display defects in nucleocytoplasmic shuttling of the GTP-bound form of the small GTPase Ran (RanGTP), which leads to abnormal transport of proteins into the nucleus. We report that microtubule stabilization in HGPS cells sequestered the nonclassical nuclear import protein Transportin-1 (TNPO1) in the cytoplasm, thus affecting the nuclear localization of its cargo, including the nuclear pore protein NUP153. Consequently, nuclear Ran, nuclear anchorage of the nucleoporin TPR, and chromatin organization were disrupted, deregulating gene expression and inducing senescence. Inhibiting

Indexed as

Cellular SenescenceActive Transport, Cell NucleusAdultAged, 80 and overbeta KaryopherinsCase-Control StudiesCell NucleusCells, CulturedChildFemaleFibroblastsHumansMaleMicrotubulesN-Terminal Acetyltransferase EN-Terminal Acetyltransferasesbeta KaryopherinsNAT10 protein, humanN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesNuclear Pore Complex ProteinsNUP153 protein, humanProto-Oncogene Proteinsran GTP-Binding ProteinRAN protein, humanTNPO1 protein, humanTPR protein, human

Identifiers

PMID29970603
PMCPMC6331045
OpenAlexW2810794539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.